Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

What do you get when 13 clean beauty experts test nearly 700 products for four months? This curated list of 74 winners that deliver big on performance and their planet-friendly promises. Once upon a ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...

Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Viscosupplementation MarketThe global viscosupplementation market is set for substantial growth, with market projections estimating an increase from USD 2,167.3 million in 2024 to USD 3,777.4 million ...

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and drug addiction.

BEAM (aka Be Amazing) is a supplement company offering a tasty lineup of dessert-inspired vegan protein powders. With options ...

Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...